InterHealth Nutraceuticals, Inc. a researcher, developer and marketer of branded nutraceuticals ingredients, announced it acquired the assets of Chick Cart Inc., a manufacturer of nutritional ingredients. Chick Cart holds the primary patents related to the manufacturing of undenatured type II collagen, which had been exclusively licensed to InterHealth for use in its UC-II joint health product.
“The acquisition of Chick Cart provides InterHealth with increased control over the supply chain and intellectual property for our UC-II product line. Chick Cart has built a best-in-class manufacturing platform and operating team, which are a welcome addition to the InterHealth team," said Paul Dijkstra, president and CEO of InterHealth.
InterHealth was acquired by Kainos Capital in November 2013.
“InterHealth has a portfolio of branded functional ingredients supported by strong clinical data," said Andrew Rosen, managing partner of Kainos Capital. “UC-II is sold to a global customer base and continues to generate strong growth in the marketplace. This acquisition will better enable InterHealth to invest in additional production capacity to support the growth of UC-II going forward."